Solving Copay Challenges for Medicare Patients in the IRA Era - July 19 Webinar

Studies show that when faced with high copays and deductibles for specialty drugs, many Medicare patients will either abandon their prescriptions or turn to companies’ free drug programs. Starting in 2025, the Inflation Reduction Act will cap patient out-of-pocket spending at $2,000. This will help some patients afford their medicines, but it isn’t a cure all.

To address the Medicare copay challenge, Real Endpoints developed?its tech-enabled platform, RE Assist, an AI-based technology platform that identifies third-party foundations offering financial assistance based on patient eligibility and funding status in a compliant and easy to navigate format.

We’re hosting a 45-minute webinar on July 19 at noon ET to demonstrate RE Assist’s capabilities and explain how life sciences companies can use the tool’s real time information to appropriately empower Medicare patients, caregivers, healthcare providers, and patient support hubs to find needed financial support for prescription medicines. ?

Tune in to hear from three Real Endpoints experts: Susan Raiola , President, Julia Murphy , VP, Patient Support Services, and Denise Wolff, PharmD , PharmD, VP of Marketing and Business Development. They will explain what RE Assist is, perform a real-time demonstration, and highlight different ways the tool can be customized for your needs.

Register here for what we promise will be an interesting and informative 45-minute session.